학술논문

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans
Document Type
Clinical report
Source
The New England Journal of Medicine. June 16, 2011, Vol. 364 Issue 24, p2293, 12 p.
Subject
Health aspects
Diagnosis
Drug therapy
Control
Usage
Africans -- Health aspects
Meningococcal meningitis -- Diagnosis
Meningococcal meningitis -- Drug therapy
Meningococcal meningitis -- Control
Meningococcal vaccines -- Usage
Meningococcal vaccines -- Health aspects
Enzyme-linked immunosorbent assay -- Usage
Meningitis, Cerebrospinal -- Diagnosis
Meningitis, Cerebrospinal -- Drug therapy
Meningitis, Cerebrospinal -- Control
Language
English
ISSN
0028-4793
Abstract
Two studies were conducted in Africa to assess the immunogenicity and safety of a meningococcal A conjugate vaccine (PsA-TT). The data obtained revealed that the new PsA-TT exhibited a safety profile similar to that of a licensed polysaccharide vaccine but elicited a significantly stronger and more persistent response from functional antibodies against group A meningococcus.